EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Use of antidepressants before, during, and after pregnancy between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss health care claims data

Alessia Danelli, Carole A Marxer, Sereina M Graber, Carola Huber, Simeon J Zürcher, Alice Panchaud, Daniel Surbek, Christoph R Meier, Julia Spoendlin

Journal of Affective Disorders · 2026

DOI: 10.1016/j.jad.2026.121483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Alessia Danelli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, S…. Hauptthemen laut MEDLINE: Antidepressive Agents, Pregnancy Complications, Depression. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Depression and anxiety are common during pregnancy, but the prevalence of antidepressant use during pregnancy in Switzerland is not well documented. We explored antidepressant use before, during, and after pregnancy in Switzerland. METHODS: We conducted a descriptive study using a Swiss health care insurance claims database (Helsana) between 2015 and 2021. We included pregnancies resulting in birth of women who were continuously insured during three 270-day periods: preconceptional, pregnancy, and postpartum. In these periods, we quantified the exposure prevalence to antidepressants overall and stratified by region and use of co-medication. Antidepressants of interest included selective serotonin reuptake inhibitors (SSRI), serotonin-norepinephrine reuptake inhibitors, Hyperici herba and others. Additionally, we assessed prevalence of antidepressant discontinuation during pregnancy. RESULTS: We included 34,584 pregnancies of whom 1386 (4.0%) were exposed (≥1 claim) to antidepressants preconceptionally, 788 (2.3%) during pregnancy, and 1273 (3.7%) postpartum. Of 1386 women with preconceptional use, 60% had no antidepressant claim during pregnancy. Antidepressant use decreased from 1.6% in trimester one to 1.1% in trimester three. The most frequently dispensed antidepressants during pregnancy were SSRIs (75.0%). Exposure to antidepressants was two-fold higher in the French-speaking region (2.6%) than in Central Switzerland (1.3%). About one-third of women continuing antidepressant treatment during pregnancy also used benzodiazepines (co-medication) at least once during this time. CONCLUSION: 4 of 100 women in Switzerland took antidepressants before pregnancy, but 60% discontinued treatment when they became pregnant. Since untreated depression in pregnancy may lead to severe long-term consequences for mother and child, this might be of concern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsPregnancy ComplicationsDepressionHumansFemalePregnancySwitzerlandRetrospective StudiesAdultSelective Serotonin Reuptake InhibitorsYoung AdultPostpartum PeriodDatabases, Factual

Stichwörter der Autor:innen

Antidepressant drugsClaims databaseDrug utilizationPharmacoepidemiologyPregnancySSRISwitzerland

Substanzen

Antidepressive AgentsSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
  • Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland; Hospital Pharmacy, University Hospital Basel, Basel, Switz…
  • Department of Health Sciences, Helsana Insurance Group, Zurich, Switzerland.
  • Department of Health Sciences, Helsana Insurance Group, Zurich, Switzerland; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
  • Institute of Primary Health Care (BIHAM), University of Bern, Switzerland; Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Switzerland; Materno-fetal and Obstetrics Research Unit, Departmen…
  • Department of Obstetrics and Gynaecology, University Hospital, University of Bern, Switzerland.

Zitieren

APA

Danelli, A., Marxer, C. A., Graber, S. M., Huber, C., Zürcher, S. J., Panchaud, A., Surbek, D., Meier, C. R., & Spoendlin, J. (2026). Use of antidepressants before, during, and after pregnancy between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss health care claims data. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2026.121483

Vancouver

Danelli A, Marxer CA, Graber SM, Huber C, Zürcher SJ, Panchaud A, et al. Use of antidepressants before, during, and after pregnancy between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss health care claims data. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2026.121483

BibTeX
@article{Danelli2026,
  author = {Danelli, Alessia and Marxer, Carole A and Graber, Sereina M and Huber, Carola and Zürcher, Simeon J and Panchaud, Alice and Surbek, Daniel and Meier, Christoph R and Spoendlin, Julia},
  title = {Use of antidepressants before, during, and after pregnancy between 2015 and 2021 in Switzerland: a retrospective analysis of Swiss health care claims data},
  journal = {Journal of Affective Disorders},
  year = {2026},
  doi = {10.1016/j.jad.2026.121483}
}
Kostenlos starten →